Gabapentin 800mg Label Image (Gabapentin 800mg Label)
Gabapentin
Product Images NDC 16590-104
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16590-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Gabapentin-fig01 (Gabapentin Fig01)
The text describes a figure labeled as "Figure 1" displaying weekly mean pain scores. The figure has a 4-week dose titration period and a 4-week fixed dose period. The treatments mentioned are placebo and Gabapentin at a dose of 3600 mg/day. The baseline and eight weeks are labeled on the x-axis. The y-axis is labeled as mean pain score. The figure suggests that Gabapentin may be statistically significant in reducing pain given the p-value mentioned (**p<0.01) compared to placebo.*
Gabapentin-fig02 (Gabapentin Fig02)
The text describes a chart denoting the weekly mean pain scores for Study 2. The chart consists of three doses; a placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The chart is split into two parts: a three-week dose titration period and a four-week fixed dose period. The chart also indicates that there is a significant difference between the results of Gabapentin and the placebo.*
Gabapentin-fig03 (Gabapentin Fig03)
The text describes the results of two controlled studies on postherpetic neuralgia (PHN), a type of nerve pain that occurs after shingles. The studies compare the effectiveness of two drugs, PBO and GBP, in reducing pain in patients with PHN. The proportion of "responders," or patients who experienced more than a 50% reduction in their pain score, is shown in Figure 3. The study data is presented in three columns, with the first column labeled as "PBO" and the second and third columns labeled as "GBP." Additionally, the text includes asterisks indicating statistical significance with p-values less than 0.01 or 0.001.*
Gabapentin-fig04 (Gabapentin Fig04)
The figure displays the responder rate of patients receiving Gabapentin compared to placebo by dose and study for adjunctive therapy in patients over 12 years old with partial seizures. The daily dose range is between 600-1800 mg. No other information is available.*
Gabapentin-structure (Gabapentin Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
